Identification of novel combined biomarkers in the diagnosis of multiple myeloma.
Yanxia JinYuxing LiangYanting SuLingyun HuiHailing LiuLu DingFuling ZhouPublished in: Hematology (Amsterdam, Netherlands) (2022)
These data suggest that the MM cases display increased glycosylation after AANL6 enrichment and that the combined expression of FBLN1 and DKK1 can be used as an effective diagnostic biomarker.